---
title: "Site Activation & Readiness"
---

## Activation Criteria (Typical)
- IRB/IEC approval in place
- Regulatory documents complete
- Training completed and documented
- EDC/IRT access granted
- IP available on-site (if applicable)

## CRA Activation Verification
- [ ] All approvals current
- [ ] DOA completed
- [ ] Training logs complete
- [ ] Systems access verified
- [ ] Pharmacy/lab ready

::: {.callout-note title="Oncology-Specific Considerations"}
- Central imaging and lab activation may be gating items
- Pharmacy readiness for cytotoxic handling
:::

::: {.callout-note title="Vaccine Trial Consideration"}
Vaccine trials often require rapid site activation and high enrollment
capacity. Site selection may prioritize throughput and population access
over therapeutic specialization.
:::

